You are invited to join me on Wednesday June 9th at 8am PT/ 11am ET at the Tribe Public Presentation & Q&A Event with Atossa Therapeutics’s (NASDAQ: ATOS) CEO Dr. Steven C. Quay, M.D., Ph.D., CFO Kyle Guse, & B. Heather Fraser, Ph.D. VP Clinical, Regulatory & CMC. The event is titled “Discussion of Atossa’s Final Data from its Phase 2 Study of Endoxifen Administered to Breast Cancer Patients Prior to Surgery.” You may join the FREE event by registering at ATOS.TribePublic.com.
Tribe Public LLC www.tribepublic.com is a sister organization to Vista Partners LLC. Tribe Public’s complimentary worldwide webinars are efficient 30-minute events that seek to provide direct corporate access to leaders of companies in industries that you care about. The events consist of a quick introduction to management a 15-minute presentation, and a brief Q&A session where you may ask the questions you care about too. Tribe events are hosted by Advisor, Investor, Entrepreneur John F. Heerdink, Jr., the Managing Partner of Tribe Public LLC.
Tribe members include Institutions, Family Offices, Registered Investment Advisors, Brokers, and Accredited Investors across the world including members from the USA & 25+ countries.
Please considering joining the Tribe for FREE today at www.tribepublic.com. Once you join you may submit your interest in meeting leaders and experts from NYSE and Nasdaq firms across all sectors via the Tribe’s “Wish List” process at Tribe Public’s website.
SPEAKER’S BACKGROUND
Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious diseases with a current focus on breast cancer and COVID-19.
He received his an M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times.
He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. Website: www.drquay.com
COMPANY BACKGROUND
Atossa Therapeutics (NASDAQ: ATOS), is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious diseases with a current focus on breast cancer and COVID-19. Website: www.atossatherapeutics.com.
Please Consider Inviting A Friend Too!
Lastly, once you have registered at ATOS.TribePublic.com, please take a moment to let other friends know how the Tribe is providing direct corporate access to leaders of industry and experts across disciplines and request that they join too.
Thanks again for your consideration and for continuing to learn more with us at the Tribe!
